DMK PHARMACEUTICALS Corp Quarterly Nonoperating Income (Expense) in USD from Q2 2011 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
DMK PHARMACEUTICALS Corp quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2011 to Q3 2023.
  • DMK PHARMACEUTICALS Corp Nonoperating Income (Expense) for the quarter ending September 30, 2023 was $1.53M, a 328% increase year-over-year.
  • DMK PHARMACEUTICALS Corp Nonoperating Income (Expense) for the twelve months ending September 30, 2023 was $4.18M.
  • DMK PHARMACEUTICALS Corp annual Nonoperating Income (Expense) for 2022 was -$1.14M, a 55% increase from 2021.
  • DMK PHARMACEUTICALS Corp annual Nonoperating Income (Expense) for 2021 was -$2.53M, a 608% decline from 2020.
  • DMK PHARMACEUTICALS Corp annual Nonoperating Income (Expense) for 2020 was $498K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $4.18M $1.53M +$1.17M +328% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $3.01M $4.3M +$4.46M Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-21
Q1 2023 -$1.45M -$2.59M -$310K -13.6% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 -$1.14M $941K +$836K +800% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-16
Q3 2022 -$1.97M $357K -$4.7M -92.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $2.72M -$160K -$115K -258% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-21
Q1 2022 $2.84M -$2.28M +$5.37M +70.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$2.53M $105K -$3.56M -97.1% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-16
Q3 2021 $1.03M $5.05M +$9.55M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$8.52M -$44.6K +$1.63M +97.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 -$10.2M -$7.64M -$10.7M -354% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $498K $3.66M +$5.58M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$5.08M -$4.5M -$4.51M -52094% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-22
Q2 2020 -$575K -$1.68M -$1.69M -15135% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-22
Q1 2020 $1.11M $3.01M +$2.96M +5879% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-22
Q4 2019 -$1.85M -$1.92M -$2.01M -2143% Oct 1, 2019 Dec 31, 2019 10-K 2021-04-15
Q3 2019 $164K $8.65K -$26.7K -75.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $191K $11.2K +$41.1K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-17
Q1 2019 $150K $50.4K +$61.9K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-18
Q4 2018 $87.6K $93.8K +$92.3K +6121% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-30
Q3 2018 -$4.66K $35.4K +$1.01M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$1.01M -$30K +$24.2K +44.7% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 -$1.04M -$11.6K +$51.9K +81.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 -$1.09M $1.51K +$65.4K Oct 1, 2017 Dec 31, 2017 10-K 2019-03-15
Q3 2017 -$1.15M -$973K -$904K -1311% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 -$251K -$54.2K -$1.77M -103% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $1.52M -$63.5K +$328K +83.8% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $1.19M -$63.9K +$711K +91.7% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-16
Q3 2016 $482K -$69K -$228K -143% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 $710K $1.72M +$1.83M Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$1.12M -$391K -$1.4M -139% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-12
Q4 2015 $278K -$775K +$126K +14% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-30
Q3 2015 $152K $159K +$343K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$190K -$113K +$16.9K +13% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 -$207K $1.01M +$845K +521% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
Q4 2014 -$1.05M -$901K +$3.64M +80.2% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-23
Q3 2014 -$4.7M -$183K -$1.11M -120% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 -$3.59M -$130K +$172K +56.9% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 -$3.76M $162K +$775K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q4 2013 -$4.54M -$4.54M -$3.32M -271% Oct 1, 2013 Dec 31, 2013 10-Q 2014-02-14
Q3 2013 -$1.22M $925K +$931K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q2 2013 -$2.15M -$303K +$1.7M +84.9% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-13
Q1 2013 -$3.85M -$613K -$610K -22455% Jan 1, 2013 Mar 31, 2013 10-K 2014-06-23
Q4 2012 -$3.24M -$1.23M -$1.22M -46826% Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-14
Q3 2012 -$2.01M -$6.33K -$9.08K -331% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-13
Q2 2012 -$2M -$2M -$1.97M -7177% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-19
Q1 2012 -$30.1K -$2.72K Jan 1, 2012 Mar 31, 2012 10-K 2013-07-03
Q4 2011 -$2.61K Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-19
Q3 2011 $2.75K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-13
Q2 2011 -$27.5K Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-08-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.